FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 維他奶國際集團有限公司 呈交日期： 2025年12月2日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00345 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（不包括庫 ...

Core Viewpoint - Vitasoy International Holdings Limited reported a decline in overall revenue for the first half of the fiscal year 2025/26, primarily due to weak performance in traditional retail channels in mainland China, despite some growth in emerging channels [2][3]. Group 1: Financial Performance - Total revenue for the six months ending September 30, 2025, was HKD 3.227 billion, a decrease of 6% from HKD 3.443 billion in the same period last year [2]. - Profit attributable to equity holders slightly increased by 1% to HKD 172 million [2]. - Revenue from mainland China, the largest market for Vitasoy, was HKD 1.778 billion, down 9% year-on-year, significantly impacting overall performance [2]. Group 2: Market Challenges and Strategies - The decline in revenue was mainly attributed to the poor performance of traditional retail channels, although all-channel business showed steady growth [2]. - Vitasoy is focusing on core product categories such as soy milk, plant-based milk, and ready-to-drink tea, implementing competitive pricing strategies and product innovations to adapt to market changes [2]. - New product launches, including the "Duck Shit Lemon Tea," and competitive pricing for existing products have helped improve market share in the soy and plant-based milk categories [2]. Group 3: Regional Performance - The Hong Kong business, including Macau and exports, remains stable, with Vitasoy consolidating its leadership in the non-alcoholic beverage market [3]. - New product launches like low-sugar white peach soy milk and the Duck Shit Lemon Tea, along with strong sales of zero-sugar lemon tea and sparkling series, have reinforced category leadership [3]. - However, adverse weather conditions and weak retail performance in Macau, along with fluctuating U.S. tariff policies affecting North American exports, have negatively impacted overall performance in Hong Kong [3]. Group 4: Competitive Landscape - Vitasoy faces increasing competition in the soy milk sector from major players like Mengniu, Yili, and DaLi Foods, which are launching their own soy milk products [3]. - The tea beverage segment is also under pressure from the rise of sugar-free tea trends and various fresh lemon tea brands, challenging Vitasoy's traditional lemon tea offerings [3]. Group 5: Leadership Transition - The company is in a gradual leadership transition phase, with 84-year-old executive chairman, Lo Kwei Cheung, still actively involved, while his daughter, Lo Chi Mei, was appointed vice-chairman in 2023, signaling a potential succession [4]. - Despite the challenges in revenue growth, strategies focused on cost control and efficiency improvements have begun to show results in maintaining profitability [4]. - To achieve a true business recovery, Vitasoy needs to seek breakthroughs in product innovation, channel expansion, and brand rejuvenation to address increasing market competition and changing consumer preferences [4].

腾讯控股回购数量102.90万股，回购金额6.36亿港元，回购最高价为623.000港元，最低价为613.000港 元，年内累计回购金额673.22亿港元；小米集团-W回购数量1000.00万股，回购金额4.02亿港元，回购 最高价为40.480港元，最低价为40.040港元，年内累计回购金额34.40亿港元；VITASOY INT'L回购数量 197.40万股，回购金额1301.62万港元，回购最高价为6.630港元，最低价为6.540港元，年内累计回购金 额3.55亿港元。 证券时报·数据宝统计显示，12月1日有46家香港上市公司进行了股份回购，合计回购2979.86万股，回购 金额11.51亿港元。 | 09966 | 康宁杰瑞制 | 23.60 | 245.73 | 10.480 | 10.250 | 2584.22 | | --- | --- | --- | --- | --- | --- | --- | | | 药-B | | | | | | | 06826 | 昊海生物科 技 | 7.49 | 206.15 | 27.700 | 27.380 | 13201.87 | | 09669 | 北森控 ...

Summary of Key Points Core Viewpoint - A total of 40 companies conducted share buybacks on December 1, 2025, with Tencent Holdings (00700) leading in both the number of shares repurchased and the total amount spent. Group 1: Buyback Details - Tencent Holdings (00700) repurchased 1.029 million shares for a total of 636 million yuan, representing 0.881% of its total share capital with a year-to-date cumulative buyback of 80.99 million shares [1][2] - Xiaomi Group-W (01810) repurchased 10 million shares for 402 million yuan, accounting for 0.290% of its total share capital with a cumulative buyback of 75.795 million shares [2] - VITASOY International (00345) repurchased 1.974 million shares for 13.0162 million yuan, which is 1.678% of its total share capital with a cumulative buyback of 17.614 million shares [2] - China Merchants Industry Holdings (01919) repurchased 945,000 shares for 12.7619 million yuan, representing 1.998% of its total share capital with a cumulative buyback of 57.543 million shares [2] - Other notable buybacks include China Feihe (06186) with 1.5 million shares for 6.3165 million yuan (2.105% of total share capital) and Mengniu Dairy (02319) with 200,000 shares for 3.0355 million yuan (0.711% of total share capital) [2][3] Group 2: Additional Companies - Other companies that conducted buybacks include: - 瑞声科技 (02018) with 300,000 shares for 11.3636 million yuan (0.420% of total share capital) [2] - 国鸿氢能 (09663) with 1.581 million shares for 7.981 million yuan (0.824% of total share capital) [2] - 美高梅中国 (02282) with 380,000 shares for 6.2746 million yuan (0.774% of total share capital) [2] - 德康农牧 (02419) with 72,600 shares for 5.3578 million yuan (0.679% of total share capital) [2] - 碧桂园服务 (06098) with 687,000 shares for 4.4254 million yuan (0.686% of total share capital) [2]

格隆汇勾股大数据显示，腾讯控股(00700)、小米集团-W(01810)、美的集团(00300)、VITASOY INT'L(00345)、中远海控(01919)、瑞声科技(02018)、国鸿氢能(09663)、中国飞鹤(06186)、美高梅中国 (02282)、德康农牧(02419)、中国石油化工股份(00386)、碧桂园服务(06098)、MONGOL MINING(00975)、津上机床中国(01651)、蒙牛乳业(02319)、科济药业-B(02171)、中集集团(02039)、明 源云(00909)、康宁杰瑞制药-B(09966)、昊海生物科技(06826)、北森控股(09669)、美丽田园医疗健康 (02373)、联易融科技-W(09959)、荃信生物-B(02509)、酷派集团(02369)、多点数智(02586)、信利国际 (00732)、绿城服务(02869)、枫叶教育(01317)、博雅互动(00434)、微泰医疗-B(02235)、富智康集团 (02038)、威高股份(01066)、粉笔(02469)、家乡互动(03798)、希玛医疗(03309)、移卡(09923)、亚洲联合 基建控股 ...

VITASOY INT'L回购明细 | 日期 | 回购股数（万股） | 回购最高价（港元） | 回购最低价（港元） | 回购金额（万港元） | | --- | --- | --- | --- | --- | | 2025.12.01 | 197.40 | 6.630 | 6.540 | 1301.62 | | 2025.11.28 | 171.00 | 6.610 | 6.430 | 1119.61 | | 2025.11.27 | 395.20 | 6.700 | 6.480 | 2592.67 | | 2025.11.26 | 396.20 | 6.790 | 6.510 | 2662.46 | | 2025.10.22 | 23.00 | 8.040 | 8.010 | 184.67 | | 2025.10.21 | 12.00 | 8.040 | 8.040 | 96.48 | | 2025.10.17 | 102.00 | 8.040 | 8.020 | 819.55 | | 2025.10.16 | 2.00 | 8.180 | 8.180 | 16.36 | | 2025.10.15 | 37. ...

格隆汇12月1日丨VITASOY INT'L(00345.HK)发布公告，2025年12月1日耗资1301.62万港元回购197.4万 股，回购价格每股6.54-6.63港元。 本文源自：格隆汇 ...

智通财经APP讯，VITASOY INT'L(00345)发布公告，于2025年12月1日，该公司斥资1301.62万港元回购 197.4万股股份，每股回购价格为6.54-6.63港元。 ...

格隆汇12月1日丨VITASOY INT'L(00345.HK)发布公告，2025年12月1日耗资1301.62万港元回购197.4万 股，回购价格每股6.54-6.63港元。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 維他奶國際集團有限公司 呈交日期： 2025年12月1日 FF305 第 2 頁 共 7 頁 v 1.3.0 FF305 確認 不適用 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00345 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | 事件 | 已發行股份（不包括庫存股份）變動 | 佔有關事件前的現有已發 | 庫存股份變動 | ...